Literature DB >> 26656071

Effect of weight loss on subclinical myocardial injury: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.

Magnus N Lyngbakken1, Torbjørn Omland2, Njord Nordstrand3, Jon Norseth4, Jøran Hjelmesæth5, Dag Hofsø3.   

Abstract

AIMS: To investigate the effect of weight loss induced by bariatric surgery and intensive lifestyle intervention on levels of circulating high-sensitivity cardiac troponin I. METHODS AND
RESULTS: We measured high-sensitivity cardiac troponin I concentrations pre- and 12 months post-intervention in 136 subjects with morbid obesity participating in a controlled clinical trial comparing the effect of intensive lifestyle intervention vs. Roux-en-Y gastric bypass. At baseline median (interquartile range) high-sensitivity cardiac troponin I levels were 2.40 (1.28-3.95) ng/L in the bariatric surgery group and 2.35 (1.38-4.40) ng/L in the intensive lifestyle intervention group (p = 0.736). The high-sensitivity cardiac troponin I concentration in a normal-weight control group was 0.90 (0.60-2.13) ng/L. During 12 months of follow-up, high-sensitivity cardiac troponin I decreased significantly more in the bariatric surgery group than in the intensive lifestyle intervention group (0.80 (0-1.80) vs. 0.15 (-0.50 to 1.00) ng/L; p = 0.002). In a multivariate logistic regression model, surgery emerged as a predictor of reduction in high-sensitivity cardiac troponin I levels (odds ratio 2.32; 95% confidence intervals 1.03-5.22; p = 0.041) independent of age, gender and other possible confounding baseline variables. In subsequent multivariate analyses, reductions in body weight and triglycerides emerged as possible mediators of reduction in circulating levels of high-sensitivity cardiac troponin I.
CONCLUSION: In patients with morbid obesity, bariatric surgery was associated with a significantly greater reduction in high-sensitivity cardiac troponin I, an index of subclinical myocardial injury, than intensive lifestyle intervention. The reduction appeared to be mediated by reductions in body weight and serum triglycerides. This suggests that weight loss following bariatric surgery may reduce cardiometabolic stress and subsequent risk of heart failure. © The European Society of Cardiology 2015.

Entities:  

Keywords:  Obesity; bariatric surgery; lifestyle intervention; troponin; weight loss

Mesh:

Substances:

Year:  2015        PMID: 26656071     DOI: 10.1177/2047487315618796

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  3 in total

Review 1.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

2.  Weight History and Subclinical Myocardial Damage.

Authors:  Chiadi E Ndumele; Laura Cobb; Mariana Lazo; Natalie A Bello; Amil Shah; Vijay Nambi; Roger S Blumenthal; Gary Gerstenblith; Scott D Solomon; Christie M Ballantyne; Elizabeth Selvin; Josef Coresh
Journal:  Clin Chem       Date:  2017-11-20       Impact factor: 8.327

3.  Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.

Authors:  Johan Sundström; Gustaf Bruze; Johan Ottosson; Claude Marcus; Ingmar Näslund; Martin Neovius
Journal:  Circulation       Date:  2017-03-03       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.